Interestingly, chemotherapy with CP stimulates CAMs to secrete CCL20, then the CCL20/CCR6 axis enhances tumor cell migration and induces the EMT mechanism, thereby leading to EMT-mediated drug resistance [181]. The gene discussed is CCL20; the disease is neoplasm.